Announce Date | 04/23/2025 |
EPS Normalized Actual | $0.51 (Beat by $0.001) |
EPS GAAP Actual | $0.51 (Beat by $0.001) |
Revenue Actual | $30.626B |
Revenue Surprise | Beat by $30626M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.59 |
EPS GAAP Estimate | $0.59 |
Revenue Estimate | $30.398B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2.935 | 9.84 | 2.87175 | 3.04226 | 1 |
Dec 2028 | 2.44 | 11.84 | 2.40439 | 2.47181 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.61 | 0.0497 | 30.626B | 1.95% | -334.96M |
FQ4 2024 (Dec 2024) | 0.56 | -0.02587 | 32.298B | 0.85% | 1794.05M |
FQ3 2024 (Sep 2024) | -0.0242 | -0.0242 | 30.213B | -0.45% | 30213M |
FQ2 2024 (Jun 2024) | 0.5 | 0.5 | 29.797B | -0.4% | 29797M |
FQ1 2024 (Mar 2024) | 0.48 | 0.48 | 30.028B | -0.37% | 30028M |
FQ4 2023 (Dec 2023) | 0.3 | 0.3 | 32.022B | 100% | 32022M |
FQ3 2023 (Sep 2023) | 0.48 | 0.48 | 30.35B | 1.01% | 30350M |
FQ2 2023 (Jun 2023) | 0.61 | 0.61 | 29.917B | 0.92% | 29917M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.59
Consensus Revenue Estimates
30.398B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.6444 | -- | 0.62766 | 0.65345 | 10 |
FQ2 2027 (Jun 2027) | 0.6073 | -- | 0.59153 | 0.61583 | 7 |
FQ1 2027 (Mar 2027) | 0.56525 | -- | 0.55057 | 0.57319 | 7 |
FQ4 2026 (Dec 2026) | 0.5132 | -- | 0.5132 | 0.5132 | 5 |
FQ3 2026 (Sep 2026) | 0.5942 | -- | 0.5942 | 0.5942 | 5 |
FQ2 2026 (Jun 2026) | 0.597 | -- | 0.597 | 0.597 | 11 |
FQ1 2026 (Mar 2026) | 0.5541 | -10.09 | 0.5541 | 0.5541 | 10 |
FQ4 2025 (Oct 2025) | 0.61 | 8.2 | 0.59987 | 0.62001 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 25.96B | -- | 25.44B | 26.24B | 11 |
FQ2 2027 (Jun 2027) | 26.48B | -- | 25.95B | 26.76B | 8 |
FQ1 2027 (Mar 2027) | 27.01B | -- | 26.47B | 27.3B | 8 |
FQ4 2026 (Dec 2026) | 32.79B | -- | 32.79B | 32.79B | 10 |
FQ3 2026 (Sep 2026) | 31.31B | -- | 31.31B | 31.31B | 7 |
FQ2 2026 (Jun 2026) | 30.9B | -- | 30.9B | 30.9B | 5 |
FQ1 2026 (Mar 2026) | 30.81B | 0.59 | 30.81B | 30.81B | 5 |
FQ4 2025 (Oct 2025) | 30.74B | -5.07 | 30.35B | 31.13B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.5603 | 0.61 | 0.0497 | 8.15% |
FQ4 2024 (Dec 2024) | 0.58587 | 0.56 | -0.02587 | -4.62% |
FQ3 2024 (Sep 2024) | -0.0242 | -0.0242 | 100% | |
FQ2 2024 (Jun 2024) | 0.5 | 0.5 | 100% | |
FQ1 2024 (Mar 2024) | 0.48 | 0.48 | 100% | |
FQ4 2023 (Dec 2023) | 0.3 | 0.3 | 100% | |
FQ3 2023 (Sep 2023) | 0.48 | 0.48 | 100% | |
FQ2 2023 (Jun 2023) | 0.61 | 0.61 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $30.96B | $30.63B | $-334.96M | -1.09% |
FQ4 2024 (Dec 2024) | $30.5B | $32.3B | $1794.05M | 5.55% |
FQ3 2024 (Sep 2024) | $0B | $30.21B | $30213M | 100% |
FQ2 2024 (Jun 2024) | $0B | $29.8B | $29797M | 100% |
FQ1 2024 (Mar 2024) | $0B | $30.03B | $30028M | 100% |
FQ4 2023 (Dec 2023) | $0B | $32.02B | $32022M | 100% |
FQ3 2023 (Sep 2023) | $0B | $30.35B | $30350M | 100% |
FQ2 2023 (Jun 2023) | $0B | $29.92B | $29917M | 100% |